tiprankstipranks
Trending News
More News >
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
US Market

Y-Mabs Therapeutics (YMAB) Revenue

Compare
515 Followers

Y-Mabs Therapeutics Revenue

Y-Mabs Therapeutics had a revenue of 20.90M in the quarter ending Mar 31, 2025, with -21.10%. This bring the company's revenue in the last twelve months to 88.66M, Decreased 1.11%. In the fiscal year ending Dec 31, 2024, Y-Mabs Therapeutics had annual revenue of 87.69M with 3.38% growth.
Revenue (ttm)
88.66M
Revenue Growth
3.38%
P/S Ratio
2.20
Revenue/Employee
$843,125
Employees
104
Market Cap
$192.96M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
87.69M2.87M+3.38%
Dec 31, 2023
84.82M19.55M+29.96%
Dec 31, 2022
65.27M30.37M+87.03%
Dec 31, 2021
34.90M14.15M+68.18%
Dec 31, 2020
20.75M+∞%
Dec 31, 2019
0.00
Dec 31, 2018
0.00
Dec 31, 2017
0.00
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis